NCT06693440 2024-11-18The Immune Assessment of PD-1 Antibody Therapy in TumorHenan Cancer HospitalRecruiting3,000 enrolled
NCT03166397 2023-01-26Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma PatientsSheba Medical CenterPhase 2 Recruiting30 enrolled